InvestorsHub Logo
Followers 25
Posts 1133
Boards Moderated 0
Alias Born 04/04/2012

Re: mike007 post# 189

Monday, 10/24/2016 8:23:00 AM

Monday, October 24, 2016 8:23:00 AM

Post# of 1726
(NASDAQ:CERU) had its "buy" rating reaffirmed by analysts at Roth Capital. They now have a $2.50 price target on the stock. 164.7% upside from the previous close of $0.94.

http://www.americanbankingnews.com/2016/10/23/cerulean-pharma-inc-ceru-given-buy-rating-at-roth-capital.html





Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DARE News